Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | TABLET;ORAL | 100MG;25MG | 0 | LOPINAVIR AND RITONAVIR | LOPINAVIR; RITONAVIR |
002 | TABLET;ORAL | 200MG;50MG | 0 | LOPINAVIR AND RITONAVIR | LOPINAVIR; RITONAVIR |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2022-03-21 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
CDER Filings
LAURUS
cder:Array
(
[0] => Array
(
[ApplNo] => 213857
[companyName] => LAURUS
[docInserts] => ["",""]
[products] => [{"drugName":"LOPINAVIR AND RITONAVIR","activeIngredients":"LOPINAVIR; RITONAVIR","strength":"100MG;25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LOPINAVIR AND RITONAVIR","activeIngredients":"LOPINAVIR; RITONAVIR","strength":"200MG;50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"03\/21\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-03-21
)
)